CAPR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

CAPRCapricor Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

CAPRCapricor Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CAPR 9

—Cedars-Sinai Medical Centerunlistedsupplier

—Johns Hopkins Universityunlistedsupplier

—Life Technologiesunlistedsupplier

—Università Degli Studi Di Roma La Sapienzaunlistedsupplier

5 more · CAPR chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

CAPRCapricor Therapeutics, Inc.

9.01▲+4.78%· post 8.98· delayed

Mkt cap$500.0MRevenue$11MQ4 FY24Revenue$22MFY24

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,360.09· delayed

After hoursNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 6 '26delayed

CAPRCapricor Therapeutics, Inc.

LLYELI Lilly & Co

9.01▲+4.78%post 8.98delayed

Price

1,360.90▼−0.28%post 1,360.09delayed

$500.0M

Mkt cap

$1.2T

Q4 FY24$11M

Revenue

$24.4BQ3 FY26

FY24$22M

Revenue

$65.2BFY25

CAPR9.01▲+4.78%vsLLY1,360.90▼−0.28%After hoursNov 6 '26delayed